LIfT BioSciences
London
About LIfT BioSciences
LIfT Biosciences is a biotech company that develops allogeneic cell therapies using Immunomodulatory Alpha Neutrophils (IMANs) derived from hematopoietic or induced pluripotent stem cells. The company leverages its patented N-LIfT platform to generate neutrophils capable of directly destroying cancer cells and reprogramming the tumor microenvironment to enhance immune recruitment. Preclinical data have shown potent activity across multiple solid tumor types, with Phase I clinical trials in metastatic cervical and head-and-neck cancer planned in partnership with the University of Galway.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.4M
- Funding stage: Early Stage Venture
- Last round: Grant (Jul 2025)
- Website: liftbiosciences.com
- Phone: +4408712261201
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/lift-biosciences-99476 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.